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We review the role of signaling pathways in regulation of the key processes of
merozoite egress and red blood cell invasion by Plasmodium falciparum and, in
particular, the importance of the second messengers, cAMP and Ca2+, and cyclic
nucleotide dependent kinases. cAMP-dependent protein kinase (PKA) is comprised
of cAMP-binding regulatory, and catalytic subunits. The less well conserved cAMP-
binding pockets should make cAMP analogs attractive drug leads, but this approach
is compromised by the poor membrane permeability of cyclic nucleotides. We discuss
how the conserved nature of ATP-binding pockets makes ATP analogs inherently prone
to off-target effects and how ATP analogs and genetic manipulation can be useful
research tools to examine this. We suggest that targeting PKA interaction partners
as well as substrates, or developing inhibitors based on PKA interaction sites or
phosphorylation sites in PKA substrates, may provide viable alternative approaches for
the development of anti-malarial drugs. Proximity of PKA to a substrate is necessary
for substrate phosphorylation, but the P. falciparum genome encodes few recognizable
A-kinase anchor proteins (AKAPs), suggesting the importance of PKA-regulatory subunit
myristylation and membrane association in determining substrate preference. We also
discuss how Pf14-3-3 assembles a phosphorylation-dependent signaling complex that
includes PKA and calcium dependent protein kinase 1 (CDPK1) and how this complex
may be critical for merozoite invasion, and a target to block parasite growth. We
compare altered phosphorylation levels in intracellular and egressed merozoites to
identify potential PKA substrates. Finally, as host PKA may have a critical role in
supporting intracellular parasite development, we discuss its role at other stages of
the life cycle, as well as in other apicomplexan infections. Throughout our review we
propose possible new directions for the therapeutic exploitation of cAMP-PKA-signaling
in malaria and other diseases caused by apicomplexan parasites.
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INTRODUCTION
Malaria is caused by apicomplexan parasites of the genus
Plasmodium. Plasmodium falciparum, the most lethal of the
species that cause malaria in humans, accounts for almost all
the deaths associated with malaria. P. falciparum parasites have
a complex life cycle during which they infect and multiply
within diverse cells and tissues of the human host and mosquito
vector. Sporozoites injected into the human host during the bite
of an infected female anopheline mosquito travel through the
bloodstream to the liver where they invade hepatocytes. The
parasites multiply in hepatocytes by schizogony and differentiate
into merozoites that are released into the blood stream and go
on to invade and multiply within a parasitophorous vacuole
inside red blood cells (RBCs) during the asexual blood stage.
During this blood stage, some of the parasites transform into
gametocytes that are ingested by mosquitoes during a blood
meal. The gametocytes undergo gametogenesis in the mosquito
midgut in response to environmental signals and form male
and female gametes that fertilize to form a zygote. The zygote
transforms into a motile ookinete that crosses the midgut
wall and forms an oocyst. Each oocyst produces thousands of
sporozoites that traverse the hemolymph and invade salivary
glands, from where they can be injected by the mosquito to
complete the parasite life cycle.
All the clinical symptoms of malaria are associated with
the asexual blood stage of the parasite life cycle. Merozoites
invade, multiply and egress from host RBCs in repeated
cycles, and the rise in parasitemia provokes the clinical
symptoms of malaria. The ability of merozoites to invade
RBCs is thus key to malaria pathogenesis. RBC invasion is
driven by merozoite motility and involves specific molecular
interactions between parasite protein ligands and host RBC
receptors (Cowman et al., 2017). Many of the parasite proteins
that mediate these interactions are located in subcellular
apical organelles called micronemes and rhoptries that are
the hallmark of apicomplexan parasites (Cowman et al.,
2017). The distinctive surface pellicle of these parasites is
comprised of the plasma membrane and the inner membrane
complex of flattened vesicles lying below the surface membrane,
which is the location of the actomyosin motor that drives
motility and invasion. Steps such as the timely secretion
of microneme and rhoptry proteins in response to external
signals as well as activation of the machinery responsible for
merozoite motility are key to successful invasion of RBCs by
P. falciparum merozoites.
Signaling pathways transduce external signals, leading to
activation of cellular processes in diverse cells. Transduction
of external signals leads to changes in levels of a common
set of intracellular second messengers such as calcium (Ca2+)
and the cyclic nucleotides, cAMP and cGMP (Singh et al.,
2010; Dawn et al., 2014; Baker et al., 2017). In P. falciparum
merozoites, these second messengers activate calcium dependent
protein kinases (PfCDPKs), cAMP-dependent protein kinase
(PfPKA; catalytic subunit PF3D7_0934800 and regulatory
subunit PF3D7_1223100) and cGMP-dependent protein kinase
(PfPKG; GeneID: PF3D7_1436600), respectively. The activated
kinases phosphorylate specific effector proteins leading to
activation of physiological responses. Exposure of P. falciparum
merozoites to a low K+ ionic environment, as found in blood
plasma, serves as a signal that raises levels of intracellular
cAMP and Ca2+ (Singh et al., 2010; Dawn et al., 2014).
cAMP is produced in merozoites by soluble adenylyl cyclase
β (PfACβ GeneID: PF3D7_0802600) (Dawn et al., 2014; Patel
et al., 2019). Mammalian ACβ homologs are usually bicarbonate
(HCO3−) sensitive (Chen et al., 2000) and HCO3− levels
in cells are generated by carbonic anhydrase (CA), which
regulates intracellular pH in cells in response to changes
in the external ionic environment (Chen et al., 2000). It
has been proposed that changes in intracellular HCO3−
levels in P. falciparum merozoites following exposure to a
low K+ ionic environment may activate PfACβ and raise
cAMP levels (Dawn et al., 2014), resulting in activation of
PfPKA (Dawn et al., 2014; Patel et al., 2019). Chemical
inhibitors of PfACβ and the catalytic subunit of PfPKA
(PfPKAc; GeneID: PF3D7_0934800), as well as inducible
knock out of genes encoding PfACβ and PfPKAc, block
invasion by P. falciparum merozoites (Dawn et al., 2014; Patel
et al., 2019), clearly implicating cAMP signaling pathways
in RBC invasion.
Transfer of merozoites to a low K+ environment also raises
the cytosolic level of free Ca2+ through a phospholipase C
(PLC) dependent pathway (Singh et al., 2010). However, the
signal transduction mechanism by which exposure to low K+
leads to activation of PLC and raised Ca2+ level remains to
be conclusively deciphered. The increased Ca2+ level activates
PfCDPK1 (GeneID: PF3D7_0217500), which has been shown to
play a role in invasion (Bansal et al., 2013; Kumar et al., 2017).
A similar rise in cGMP levels activates PfPKG, which plays a
role in merozoite egress from RBCs containing mature schizonts
(Collins et al., 2013b). However, the signal that triggers a rise in
cGMP in merozoites remains to be identified.
In this review, we will primarily focus on the role of cAMP
and PKA in signaling mechanisms that regulate physiological
processes in P. falciparum merozoites during RBC invasion. We
will also explore how cAMP-dependent signaling pathways could
be targeted with small molecule inhibitors to block invasion.
Such inhibitors may serve as leads for the development of novel




In eukaryotes, the PKA catalytic (C) subunits (Cα, Cβ with
several splice variants, Cγ and PrKX) and the functionally
non-redundant isoforms of the regulatory subunit (RIα, RIβ,
RIIα, and RIIβ) form an inactive PKA holoenzyme complex
(R2C2). Upon consecutive binding of cAMP to the tandem
cyclic nucleotide binding (CNB) domains (CNB-A and CNB-
B at the C-terminus of the regulatory subunit) the C-subunits
are released and can phosphorylate target molecules. In contrast
to the mammalian enzyme there is only one R-subunit present
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in Plasmodium PfPKAr or PfPKA-R (GeneID: PF3D7_1223100)
(Merckx et al., 2008), a hybrid between RI and RII based
on the primary sequence combining features of the human
isoforms type I and type II including also the auto-inhibitory
sequence of PfPKAr (Haste et al., 2012). Interestingly, the
N-terminus of PfPKAr differs significantly from the mammalian
counterparts and most likely has specific functions for subcellular
localization (Haste et al., 2012). Although detailed biochemical
studies are missing, there is evidence that PfPKAr inhibits
a PKA activity in parasite extracts in response to cAMP
suggesting a similar regulatory mechanism as for mammalian
PKA (Merckx et al., 2008).
Given that CNBDs of PfPKAr (CBD) and the human
homologs have a sequence identity of about 35% (Littler et al.,
2016), PfPKAr specific cAMP analogs (Figure 1) could be
a starting point for the development of antimalarial drugs
that specifically dysregulate PKA signaling in P. falciparum.
However, a general limitation of cAMP and its analogs
is poor membrane permeability due to their polar ionic
structure (Posternak and Weimann, 1974). Furthermore, cAMP
is rapidly degraded by phosphodiesterases (Coulson et al., 1983).
Dibutyryl-cAMP (DB-cAMP/N6, 2′ O-dibutyryladenosine-3′, 5′-
cyclic monophosphate, also known as db-cAMP, Bucladesine and
DiB) is a membrane-permeant activator of PKA in mammalian
cells (Bartsch et al., 2003; Werner et al., 2011). Already in
1980, DB-cAMP was applied to Plasmodium cultures in order to
investigate induction of gametocyte formation, and interestingly,
DB-cAMP turned out to be only as potent as cAMP (Kaushal
et al., 1980), which was surprising, because of the more than
20-fold increased lipophilicity of DB-cAMP compared to cAMP
(Braumann and Jastorff, 1985).
Based on the complex membrane structures of a RBC infected
with Plasmodium (Dearnley et al., 2012), it is conceivable that
the permeability of DB-cAMP (Figure 1) differs from that
in other cell types, such as platelets, CHO cells, or rat C6
glioma cells (Bartsch et al., 2003; Werner et al., 2011). DB-
cAMP is cleaved by intracellular esterases to butyrate and N6-
monobutyryl cAMP, activating PKA. However, N6-monobutyryl
cAMP may activate PfPKA less efficiently even if present at high
concentration in the infected cell. Butyrate has other distinct
biological properties and interferes with second messenger
signaling pathways. Treatment of Plasmodium sporozoites with
DB-cAMP initiates motility even more efficiently than the high
intracellular cAMP level generated by forskolin (an activator of
adenylyl cyclase), or IBMX (an inhibitor of cyclic nucleotide
phosphodiesterase) (Kebaier and Vanderberg, 2010). Dawn
and co-workers (Dawn et al., 2014) demonstrated that in
a parasite line overexpressing PfPKAr (PHL dhfr-PfPKAr),
application of DB-cAMP restores both PKA activity and
parasite growth. The extracellular addition of DB-cAMP to
non-infected RBCs was also used to examine whether the
changes in structural and mechanical deformability of non-
infected RBCs during P. falciparum infection is cAMP-dependent
(Paul et al., 2019).
Other membrane permeable cAMP analogs like N6-benzoyl-
cAMP (6-Bnz-cAMP/6-Bz-cAMP, Figure 1) and 8-Bromo-cAMP
(8-Br-cAMP, Figure 1) have been described as PfPKA activators
(Beraldo et al., 2005; Merckx et al., 2008). 6-Bnz-cAMP is
known as a selective activator of mammalian PKA with a
high lipophilicity, good membrane permeability and increased
stability toward phosphodiesterase activity. Interestingly, 6-Bnz-
cAMP shows selectivity for the cAMP-binding pocket A of the
functionally distinct human PKA regulatory subunit isoforms
type I and II (Schwede et al., 2000), which corresponds to PfPKAr
CBD1. Treatment of P. falciparum cultures with 6-Bnz-cAMP
speeds up development to the schizont stage (Beraldo et al., 2005).
In the same study, application of 2 mM CaCl2 together with
6-Bnz-cAMP increased the cytoplasmic Ca2+ concentration in
intact parasites, and this increase could be inhibited by PKA
specific protein kinase inhibitor (PKI).
Modification of cAMP with bromine (8-Br-cAMP, Figure 1)
generates a more lipophilic and thus more membrane-permeant
compound. This analog has effects that are comparable with those
of DB-cAMP, restoring the growth deficit of transgenic parasites
overexpressing PfPKAr (Merckx et al., 2008), even though 8-
Br-cAMP is slowly metabolized by phosphodiesterase activity.
Phosphorothioate-modified cAMP analogs like Sp-8-Br-cAMPS
(8-Bromoadenosine-3′, 5′-cyclic monophosphorothioate, Sp-
isomer, Figure 1) have been developed and recently tested on
Plasmodium by Littler and co-workers (Littler et al., 2016). In
contrast to the parent compound 8-Br-cAMP, the axial one
of the two exocyclic oxygen atoms in the cyclic phosphate
moiety (“Sp” stands for the S-isomer corresponding to the
R/S nomenclature related to the phosphorus) is modified by
sulfur (cAMPS). Sp-8-Br-cAMPS is about two-times more
lipophilic than 8-Br-cAMP and 4 times more than cAMP,
respectively (Schaap et al., 1993; Schwede et al., 2000).
Sp-2-Chloro-cAMPS (Sp-2-Cl-cAMPS, Figure 1) is another
cAMP-analog with increased lipophilicity and phosphodiesterase
stability. Direct comparison between these two analogs and
6-Bnz-cAMP for their capacity to block proliferation of the
P. falciparum 3D7 asexual blood stage parasite showed a
half maximal effect at approximately 4 and 11 µM for Sp-
2-Cl-cAMPS and Sp-8-Br-cAMPS, respectively. In contrast,
millimolar range 6-Bnz-cAMP had minimal effect. Binding
assays with purified PfPKAr revealed affinities of 1.2 nM,
8.9 nM, and 1.3 µM for cAMP, Sp-2-Cl-cAMPS and Sp-
8-Br-cAMPS, respectively. Furthermore, Sp-8-Br-cAMPS does
not bind CBD2, whereas cAMP and Sp-2-Cl-cAMPS bind
with single digit nanomolar affinities to both sites. Crystal
structures of PKA-R subunits with the membrane permeable
Sp-2-Cl-cAMPS and with cAMP reveal a similar architecture
(Littler et al., 2016). However, a unique interaction between
PfPKAr Cys-437 in the CBD2 and the C2 position of the
adenosine base was discovered, which could be targeted for
the development of Plasmodium selective cAMP analogs. Thus,
novel agonistic (activating) cAMP analogs may be developed to
cause uncontrolled premature activation of PfPKAr to impact
parasite survival.
Besides the PKA-activating cyclic nucleotide analogs
presented here, antagonistic analogs have been developed.
In Rp-8-Br-cAMPS (8-BrcAMP-RP isomer, Figure 1) the
sulfur modification is at the equatorial position of the
cyclic phosphate moiety. In human PKA-R, Rp-8-Br-cAMPS
Frontiers in Microbiology | www.frontiersin.org 3 May 2021 | Volume 12 | Article 684005
fmicb-12-684005 May 18, 2021 Time: 17:20 # 4
Lasonder et al. cAMP-Signaling in Plasmodium falciparum
FIGURE 1 | Chemical structures of cAMP and analogs thereof. Numbers in the cAMP structure highlighted in gray indicate the position 1–9 in the adenine ring, 1′–6′
in the sugar moiety as well as the oxygen positions of the cyclic phosphate moiety. The modifications of the depicted analogs are highlighted in color according to
their positions: Pos. 2, 6, and 8 in the adenine ring in purple, blue, and orange, respectively. The 2’ position in the sugar moiety is depicted in green and the
exchange of exocyclic oxygen to sulfur in the cyclic phosphate moiety is highlighted in yellow.
occupies cyclic nucleotide binding sites without causing
holoenzyme dissociation. Rp-8-Br-cAMPS is slightly more
lipophilic than cAMP and is not metabolized by mammalian
phosphodiesterases. In humans, Rp-8-Br-cAMPS discriminates
between the functionally distinct PKA regulatory subunit
isoform types I and II, preferring type I (Gjertsen et al., 1995)
and thus, provides additional selectivity. Rp-8-Br-cAMPS was
tested on Plasmodium in comparison to PKI and both were able
to inhibit the melatonin induced increase of parasitemia by up
to 68 and 90%, respectively (Beraldo et al., 2005). Finally, the
single parasite EPAC-like gene has been recently genetically
demonstrated to be non-essential for parasite growth and
merozoite egress by Patel et al. (2019). Therefore, any effect
previously observed by Dawn et al. (2014) by Epac agonist
(8-pCPT-2’-O-Me-cAMP), and antagonists (ESI-05 ESI-09)
may be either due to targeting of an unidentified EPAC-like
protein in the parasite that provides redundancy, or due to
off-target effects.
More detailed structural studies, for example using
nuclear magnetic resonance (NMR) and molecular dynamics
simulations, as described recently for PfPKG (Byun et al.,
2020), may unravel the distinct conformational changes
induced by cyclic nucleotide binding. This may allow the
design of high affinity, PfPKAr-selective cyclic nucleotide
analogs, which are both membrane permeable and stable against
phosphodiesterase degradation.
PfPKAc AS A TARGET FOR
DEVELOPMENT OF ANTI-MALARIAL
DRUGS
PfPKA phosphorylates a range of substrates in merozoites
during RBC invasion, and if this activity is essential for asexual
blood stage growth, then it is a target for drug development.
This conclusion is supported by earlier drug treatment (Syin
et al., 2001) and more recent genetic (Patel et al., 2019;
Wilde et al., 2019) studies. The identification and use of
specific pharmacological inhibitors of PKA activity, together
with methods to genetically modify, delete or knockdown the
PfPKAc gene, can provide powerful insights into the role of PKA
and the signaling pathways in which it is involved. Due to the
highly conserved ATP-binding pocket in PfPKAc, commercially
available PKA inhibitors have questionable specificity (Murray,
2008) and are unlikely to have greater activity against the parasite
than the host enzyme. There is, therefore, a need to develop new
inhibitors, for example by biochemical screening of compounds
against purified recombinant PfPKAc in vitro, as described
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recently for PfCDPK1 (Ansell et al., 2014). New inhibitors must
be able to penetrate into the parasite and must be specific for
PfPKA. Accessibility to the enzyme requires that the compound
can cross the erythrocyte plasma membrane, the parasitophorous
vacuolar membrane and the parasite plasma membrane. The
compound must be active at very low concentration as part of
the requirement for high specificity. Additional criteria apply to
all compounds considered to be lead compounds for further drug
development (Burrows et al., 2017). Many kinase inhibitors are
ATP-mimetics and the issue of specificity is a major concern,
because ATP binding sites may be highly conserved. For example,
a series of imidazopyridazine compounds, developed as potent
inhibitors of PfCDPK1, were found to also inhibit PfPKG, which
has a quite similar ATP binding pocket, and these inhibitors kill
parasites through PfPKG inhibition (Green et al., 2015). Other
properties of kinases, and regions outside of the ATP binding site
may also be targeted for drug development. Post-translational
modifications, and the binding of interacting proteins and
subunits such as PKAr may be inhibited by small molecules (see
previous section). For example, cAMP analogs binding to PKAr
perturb the cellular function of PKA (Littler et al., 2016). PKAr is
N-myristylated and inhibitors of N-myristyl transferase (PfNMT;
GeneID: PF3D7_1412800) may have a profound effect on PKA
function due to loss of membrane binding and subcellular
localization signals in their presence (Schlott et al., 2018).
Genetic manipulation of the parasite allows experimental
validation of whether the PKAc and PKAr genes are essential,
enables the on-target specificity of inhibitors to be substantiated,
facilitates a precise dissection of the requirement for particular
amino acid residues and permits the use of mutations identified
in PKA-specific drug-selected parasites as a key part of
structure-function studies (Schlott et al., 2019). In particular,
the application of CRISPR-Cas9 methodology enables precise
changes to be introduced into the genome. This technology can
be coupled with additional tools such as the rapamycin-inducible
DiCre system to engineer specific deletions or rearrangements
in the PKAc and PKAr genes (Collins et al., 2013a; Jones
et al., 2016; Knuepfer et al., 2017), with the glmS ribozyme
approach to knockdown expression of the genes (Prommana
et al., 2013) and with systems that manipulate protein stability
(Armstrong and Goldberg, 2007). Incorporation and expression
of a second copy of the PKA genes that can be modified at will,
in conjunction with deletion of the endogenous gene enables
complementation studies to identify the importance of particular
residues in the protein (Koussis et al., 2020). For example,
(inducible) replacement of amino acids that are phosphorylated,
the introduction of critical changes in the PKAc ATP-binding
site, or the replacement of the myristylated N-terminal glycine




Although P. falciparum kinases, including PfPKA, have the
potential to be targeted using ATP-competitive inhibitors, the
kinase domains are conserved and thus share many structural
similarities to their human counterparts. Consequently, it
remains a major challenge to achieve inhibitor specificity for
parasite kinase over host kinase. An alternative strategy is to
exploit areas of evolutionary structural divergence to selectively
target a Plasmodium kinase of interest. Although kinase domains
may be conserved across the eukaryotic superfamily, many
are flanked by additional domains that serve to regulate the
catalytic function of the kinase domain or mediate protein–
protein interactions (PPIs) that are critical for kinase-mediated
signaling. These regions may be structurally divergent and serve
as unique targets for selective inhibition of a kinase of interest.
While PPIs may be attractive for inhibitor development,
they are often mediated by interfaces that are shallow and
elongated, and therefore cannot be easily disrupted using small
molecules. Larger, peptide-based inhibitors have been developed
to target these surfaces and interactions, and there are several
examples developed to target Plasmodium proteins (Helton
and Kennedy, 2020). In eukaryotes, a family of A kinase
anchoring proteins (AKAPs) interacts with PKA to ensure
the correct location for its biological function (Kennedy and
Scott, 2015; Bucko and Scott, 2021). A chemically constrained
peptide, STAD-2 was designed to mimic a conserved docking
helix shared by AKAPs, and which binds directly to the
docking/dimerization domain (D/D domain) of human PKA
R-subunits (Flaherty et al., 2015). Although no Plasmodium
AKAP protein has been identified, an AKAP-like protein
(GeneID: PF3D7_0512900) was found (Bandje et al., 2016),
suggesting that the mechanism of PKA-centered micro-signaling
complexes is conserved in parasites. Although the Plasmodium
AKAP-like protein lacks a homologous D/D domain, it was
hypothesized that human AKAPs may play a role in regulating
either parasite or human PKA during infection, STAD-2 was
added to a culture of Plasmodium-infected RBCs (Flaherty
et al., 2015) and interestingly, this peptide permeated into
infected, but not uninfected, RBCs and could be detected in
the parasitophorous vacuole. In addition, the peptide induced
lysis of infected RBCs through a PKA-independent mechanism.
While this peptide apparently did not disrupt the PPI and AKAP
function in P. falciparum-infected RBCs, the work demonstrated
for the first time that hydrocarbon-stapled peptides can penetrate
into intra-erythrocytic Plasmodium parasites. Potentially, such
peptides may be engineered to target parasite-specific PPIs.
The constrained peptide methodology was then applied to
target PfCDPK1, a Plasmodium kinase that has been implicated
in merozoite invasion (Flaherty et al., 2019). PfCDPK1 contains
two additional domains that allosterically regulate its kinase
activity, a calmodulin-like domain that acts as a calcium
sensor and a Junction-domain (J-domain) that undergoes
significant conformational change upon calcium binding. Since
the J-domain makes critical contacts with the catalytic domain
to allow kinase activation, hydrocarbon-stapled peptides were
designed to mimic the J-domain and sequester PfCDPK1 in
an allosterically inhibited conformation. The peptide selectively
permeated infected RBCs, and was found in late-stage schizonts,
inhibiting the targeted kinase and blocking merozoite invasion.
This study demonstrates the feasibility of using stapled peptides
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to target specific parasite proteins and provides a foundation
for broadening the repertoire of compound classes to access
the parasitophorous vacuole and intraerythrocytic parasite,
extending the possible proteins that can be targeted using non-
small molecule approaches.
A DYNAMIC SIGNALING COMPLEX
CONTAINING PfPKA AND PfCDPK1 IS
ESSENTIAL FOR RBC INVASION AND
CAN BE TARGETED TO BLOCK
ASEXUAL BLOOD STAGE GROWTH
A rise in cytosolic levels of cAMP and Ca2+ in merozoites
suspended in a low K+ ionic environment that mimics
extracellular (EC) ionic conditions, activates PfPKA and
PfCDPK1, respectively, which play essential roles in RBC
invasion. Interestingly, quantitative phosphoproteomics of
merozoites suspended in EC buffer, or in buffer mimicking
intracellular (IC) ionic conditions with high K+, showed
increased phosphorylation of both PfPKAr and PfCDPK1
in EC buffer compared to IC buffer (More et al., 2020).
The scaffold protein, 14-3-3, is known to interact with
phosphorylated residues of target proteins to assemble protein
complexes (Agarwal-Mawal et al., 2003; Kawamoto et al.,
2015). Antibodies against Pf14-3-3I (GeneID: PF3D7_0818200)
immunoprecipitated Pf14-3-3, PfPKAr and PfCDPK1 from
lysates of merozoites suspended in EC buffer suggesting that
Pf14-3-3I and phosphorylated PfPKAr and PfCDPK1 form a
multi-protein signaling complex (More et al., 2020). In other
eukaryotic cells, the subcellular spatio-temporal control of PKAc
activity is maintained by interaction with AKAPs. However,
AKAP homologs are absent in P. falciparum (see above).
The function of anchoring PfPKA is mediated by the scaffold
protein, Pf14-3-3I (Jain et al., 2020; More et al., 2020). We
have not determined the subcellular localization of Pf14-3-3I
in merozoites, but previously we localized PfCDPK1 close to
the plasma membrane in merozoites (Alam et al., 2015). Since
Pf14-3-3I is in a complex with PfCDPK1 and PfPKA it follows
that both Pf14-3-3I and PfPKA are also plasma membrane
proximal in merozoites.
Importantly, comparing the immunoprecipitates from lysates
of merozoites suspended in IC and EC buffers indicated that
the protein complex assembles only under EC ionic conditions,
therefore assembly of the signaling complex, which is essential
for merozoite invasion of RBCs, and is dynamic and only
found under conditions that mimic blood plasma. Addition of
phosphorylated peptides based on the PfPKAr binding site for
Pf14-3-3I to parasite cultures inhibits signaling complex assembly
and blocks the microneme secretion that is essential for RBC
invasion. Similarly, BV02, a small molecule inhibitor of 14-3-3
interactions in mammalian cells, inhibits Pf14-3-3I interaction
with PfPKAr and PfCDPK1 and blocks both microneme
secretion and RBC invasion by P. falciparum merozoites (More
et al., 2020). These studies indicate that targeting the assembly
of the Pf14-3-3I-mediated signaling complex may be a viable






One key question is whether all PKA-mediated phosphorylation
has functional significance, or does PKA have promiscuous
kinase activity that has no consequence for parasite development?
If the phosphorylation of specific substrates, for example in
signaling pathways, is essential, those substrates are also potential
drug targets. PKA substrates can be identified by comparing the
phosphoproteomes of parasites at different stages of development
or treated with a PKA-specific inhibitor or with a genetic deletion
or knockdown of the PKA gene.
Putative PKA therapeutic targets can be identified by
establishing protein kinase – protein substrate relationships from
large scale protein phosphorylation data sets. Recent advances in
liquid chromatography-tandem mass spectrometry have enabled
large scale phosphoproteome screening of various P. falciparum
life cycle stages, which has resulted in the detection of around
27,200 unique phosphorylation sites in proteins of intracellular
asexual blood stage parasites (Solyakov et al., 2011; Treeck et al.,
2011; Lasonder et al., 2012; Pease et al., 2013, 2018; Collins et al.,
2014; Alam et al., 2015; Kumar et al., 2017; Flueck et al., 2019;
Patel et al., 2019) and 2,250 unique phosphorylation sites in
proteins of extracellular merozoites (Lasonder et al., 2015; More
et al., 2020).
Patel et al. (2019) studied directly the PKA-substrate
relationship during the asexual erythrocytic cycle by a
quantitative phosphoproteome analysis, comparing wild
type parasites with transgenic parasites in which genes encoding
PfPKAc and PfACβ (that synthesizes cAMP) were deleted
using an inducible recombinase system. The study reported
a list of 61 high confidence PfPKA substrate phosphorylation
sites (Supplementary Table 1) from the intersection of three
quantitative phosphoproteomes (Flueck et al., 2019; Patel
et al., 2019). The PfPKA substrate sites have a common
feature: the levels of phosphorylation of the site in parasites
deficient in PfPKAc and PfACβ were reduced compared to
wild type phosphorylation levels as a result of lost kinase
activity, and the phosphorylation sites in parasites deficient
in phosphodiesterase β (PfPDEβ, GeneID: PF3D7_1321500; a
master down-regulator of PfPKA) were upregulated compared
to wild type phosphorylation levels by the hyperactivation of
PfPKA activity. The set of phosphorylation sites upregulated in
PfPDEβ conditional knock down parasites was obtained from
previous work (Flueck et al., 2019). The majority (46/61) of
the phosphorylation sites contained the broad P. falciparum
PKA consensus phosphorylation motif (Flueck et al., 2019),
which included one or more basic residues at positions
−2, −3, and −4 relative to the phosphorylated amino acid
(Supplementary Table 1).
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More et al. (2020) studied differences in P. falciparum protein
phosphorylation levels in intra-erythrocytic merozoites prior
to egress from the infected cell versus extracellular merozoites
competent for red blood cell invasion. Switching merozoites from
IC to EC conditions leads to a surge in cAMP concentration
and activation of PfPKA, promoting merozoite invasion of
RBCs (Dawn et al., 2014). EC conditions are characterized
by a low K+ concentration that also triggers an increase in
Ca2+ levels in merozoites, and thereby activation of Ca2+-
dependent protein kinases such as, but not only, PfCDPK1
(Fang et al., 2018). More et al. (2020) reported that 196
phosphorylation sites (Supplementary Table 2) are upregulated
in EC conditions, and that this increase was not blocked by
the Ca2+ chelator BAPTA-AM. Thus, increased phosphorylation
at these sites likely arose directly or indirectly from increased
PfPKA activity and not activity of Ca2+-dependent kinases. That
said, it’s also likely that protein kinases other than PfPKA are
also activated upon switching merozoites from IC to EC buffer
containing BAPTA-AM. Therefore, an additional stringency filter
was added by requiring that the phosphorylation sites are located
within the broad PKA consensus sequence motif, and this
restriction reduced the number of phosphorylation sites to 71,
identifying 35 proteins as potential PfPKA therapeutic targets
(Supplementary Table 2).
We also exploited the ensemble of phosphoproteome data
(Treeck et al., 2011; Lasonder et al., 2012, 2015; Pease et al.,
2013, 2018; Collins et al., 2014; Alam et al., 2015; Kumar
et al., 2017; Flueck et al., 2019; Patel et al., 2019; More
et al., 2020) to identify novel potential PKA therapeutic targets
by (1) establishing putative substrate-PKA relationships from
phosphorylation site sequence motifs and by (2) requiring a
putative protein - protein interaction between substrate and PKA
to be present, as defined in the STRING database. We had
previously established the sequence: Arg or Lys followed by any
two residues immediately upstream of the phosphorylated Ser or
Thr [(R/K)xx(pS/pT)], as the core consensus motif that was most
abundant in PKA substrates found in a P. falciparum merozoite
phosphoproteome (Lasonder et al., 2015). A list of potential
PKA substrates was compiled by extracting 5,735 phosphorylated
peptide sequences encompassing this PKA consensus motif from
the data reported in 12 P. falciparum phosphoproteome studies
(Supplementary Table 3). The PfPKA consensus motif sequence
(R/K)xx(pS/pT) is 30-times more abundant in the two merozoite
phosphoproteomes (Lasonder et al., 2015; More et al., 2020)
compared to the phosphoproteomes of intracellular asexual
blood stages (Solyakov et al., 2011; Treeck et al., 2011; Lasonder
et al., 2012; Pease et al., 2013, 2018; Collins et al., 2014; Alam et al.,
2015; Kumar et al., 2017; Flueck et al., 2019; Patel et al., 2019)
suggesting an important role for PfPKA phosphorylation of these
sites in proteins during merozoite invasion of erythrocytes.
Within the list of 5,735 phosphorylated peptides with the
PfPKA core motif, we detected four sequence subclasses (acidic,
basic, Pro-directed, and other/neutral) on the basis of the
chemical properties of the amino acid side chains (Figure 2).
The 101 peptides classified as the Pro-directed subclass were
excluded as potential PfPKA substrates because of (1) functional
divergence of the proteins from the other subclasses established
by a GO enrichment analysis, (2) absence of this motif in
known PfPKA substrates, and (3) Pro-directed sequences are
classified as cyclin dependent kinase substrates in the Kinexus
database comprised of 177,000 human phosphorylation sites1.
From the remaining 5,634 potential PfPKA phosphorylation sites
in 1,675 P. falciparum proteins, 5,478 were excluded, because
they are in proteins without evidence of a PfPKA interaction
in the STRING protein interaction database. This is probably a
severe exclusion criterion, because it’s likely that many PfPKA –
protein interactions in malaria parasites have yet to be discovered
and entered into the STRING database. However, applying this
stringent selection resulted in a list of just 156 phosphorylation
sites in 30 putative PfPKA substrates (Supplementary Table 3).
In total, we established 109 putative PfPKA – protein
substrate relationships from large scale P. falciparum protein
phosphorylation data sets (Supplementary Table 4). Previously,
we have described that protein ubiquitylation dramatically
increases as schizonts develop into merozoites (Green et al.,
2020) and within the list of 109 putative PKA substrates
there are 59 ubiquitylated proteins that we had identified
previously in the asexual blood stage ubiquitylome (Green
et al., 2020). This is a 5.9-fold enrichment compared to
the total P. falciparum proteome (p = 0.00001). Remarkably,
almost all proteins with a PfPKA substrate phosphorylation
motif (57) were detected as ubiquitylated in merozoites and
heightened phosphorylation of two ubiquitin carboxyl-terminal
hydrolases (GeneIDs: PF3D7_0104300, PF3D7_0726500), an
E3 ubiquitin-protein ligase (GeneID: PF3D7_1004300) and a
ubiquitin-like protein (GeneID: PF3D7_1132000) was observed
(Supplementary Table 4).
The biological functions of these putative PfPKA substrates
were assessed by a GO enrichment analysis (Figure 3). From
this analysis it is clear that PfPKA-mediated phosphorylation
is involved in facilitating merozoite invasion of RBCs. Another
remarkable feature is the strong influence on cGMP-dependent
metabolic processes, as PfPKG has been clearly established
as crucial for merozoite egress rather than invasion, where
PfPKA plays an essential role (Flueck et al., 2019; Patel
et al., 2019). The observation that cGMP phosphodiesterase
α (PfPDEα; GeneID: PF3D7_1209500); PfPDEβ and PfPKG
are all likely phosphorylated by PfPKA, strongly suggests an
interplay between cGMP- and cAMP-signaling processes in
intra-erythrocyte parasite development prior to merozoite egress
(Flueck et al., 2019), similar to what occurs in mammalian cells
(Taylor et al., 2013). However, phosphorylation of these cGMP-
signaling enzymes does not increase in extracellular merozoites
in EC buffer (Supplementary Table 2). This is consistent with
a positive role for PfPKA-mediated regulation of cGMP-PKG-
mediated merozoite egress. Moreover, increased phosphorylation
of PfACβ and PfPKAc is observed in egressed extracellular
merozoites, entirely consistent with the role of cAMP-dependent
PfPKA in merozoite invasion of RBCs, established using genetic
methodologies (Flueck et al., 2019; Patel et al., 2019).
The list of 109 putative PfPKA substrate proteins enabled
exploration of putative PfPKA-mediated signaling networks
1http://www.kinexus.ca/
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FIGURE 2 | Sequence logos of potential PKA substrate phosphorylation sites. Sequence logos of phosphorylation sites with a basic residue at position –3,
extracted from 12 Plasmodium falciparum phosphoproteome studies (Treeck et al., 2011; Lasonder et al., 2012, 2015; Pease et al., 2013, 2018; Collins et al., 2014;
Alam et al., 2015; Kumar et al., 2017; Flueck et al., 2019; Patel et al., 2019; More et al., 2020), were generated with Web Logo 3 (Crooks et al., 2004) and divided
into the acidic, basic and neutral PfPKA motifs and the proline-directed non-PKA motif.
by analyzing the protein – protein interactions from the
STRING database (Szklarczyk et al., 2019), which resulted in
the identification of the six sub-networks depicted in Figure 4
and listed in Supplementary Table 4. Clusters 1, 3, and 4 are
comprised of protein complexes localized within the nucleus,
with clusters 1 and 4 involved in metabolism and cluster 4
in gene expression. Cluster 2 contains proteins linked to the
pellicle, but of largely unknown function. Clusters 5 and 6 are
both associated with the apical end of the parasite, and are
interconnected via PfCDPK1 that is present in both clusters.
Cluster 5 contains PfPKA, PfPDEβ and PfAcβ, the genes that
were selected by Patel et al. (2019) for deletion, with analysis
of the resultant phosphoproteomes to identify putative PfPKA-
targets, as described above. The critical role of cAMP signaling
in merozoite invasion is illustrated by eight core proteins
from cluster 5 [PfAMA1 (GeneID: PF3D7_1133400), PfCDPK1,
PfACβ, PfGCα (GeneID: PF3D7_1138400), PfPDEα, PfPDEβ,
PfPKAr, and PfPKAc], and this analysis has been reviewed
recently (Perrin et al., 2020). Our data suggest that other proteins
from cluster 5 play a role in invasion mediated by PfPKA as
well. It is interesting to note that the function of 14 out of the
18 proteins in cluster 5 has been studied by gene disruption
and phenotypic analysis in Plasmodium berghei. For six proteins,
including PfROM4 (GeneID: PF3D7_0506900) and PfDHHC7
(PF3D7_0528400), which are not members of the core of eight
proteins in cluster 5, gene disruption resulted in a phenotype in
the asexual blood stages. The gene disruption information from
the RMgmDB database2 for all 109 putative PfPKA substrates
is provided in Supplementary Table 4. There are 34 P. berghei
2https://www.pberghei.eu/
orthologs (31%) showing a clear phenotype in asexual blood
stages following gene disruption.
PfPKA-mediated phosphorylation of Ser610 in the
intracellular C-terminal domain of PfAMA1 (Treeck et al.,
2009) has been proposed to induce a conformational change
that is a necessary late step in successful merozoite invasion
(Patel et al., 2019). Substitution of Ser610 abolished the ability of
mouse PKA to phosphorylate recombinant PfAMA1, implying
that Ser610 is the only PfPKA site in AMA1 (Patel et al., 2019).
It was, therefore, surprising that Ser610 was found to be already
phosphorylated in merozoites prepared in IC buffer (More
et al., 2020). However, increased phosphorylation of Ser590 of
PfAMA1 was observed in merozoites in EC buffer compared to
IC buffer (Supplementary Table 2). One way to reconcile these
contrasting observations is to propose that phosphorylation of
S590 occurs in extracellular merozoites only if Ser610 has already
been phosphorylated; and, indeed, phosphorylated Ser610
is observed already in non-egressed merozoites in IC buffer
(Supplementary Table 2). Perhaps, a conformation change
induced by Ser610 phosphorylation (Patel et al., 2019) exposes
Ser590 in egressed merozoites, allowing its phosphorylation to
lock PfAMA1 in an invasion competent conformation.
We should point out that activating PfPKA may not
lead to a systematically higher phosphorylation of PfPKA-
target substrate proteins. An interesting example is merozoite
surface protein 1 (PfMSP1, GeneID: PF3D7_0930300) with
two phosphorylation sites, Ser116 and Ser1582 (Supplementary
Table 3), which are potentially significant. Position 116 is
in the N-terminal fragment that is present on the merozoite
surface, as part of a protein complex. Proteolytic cleavage
by PfSUB2 (GeneID: PF3D7_1136900) releases this complex
from the merozoite surface during invasion, except for the
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FIGURE 3 | Gene Ontology (GO) enrichment analysis of 109 putative PfPKA substrate proteins. GO enrichment analysis of proposed PfPKA substrates from
Supplementary Table 4 was performed with the GO enrichment analysis tool of PlasmoDB (https://plasmodb.org/plasmo/app), and the results are depicted in a
histogram for terms with p adjusted (Benjamini-Hochberg) < 0.05. Terms excluded from the histogram are those with less than three PfPKA substrates, as well as
very broad terms with more than 2,000 proteins in the Plasmodium falciparum proteome.
C-terminal PfMSP1-19 (Blackman et al., 1991). Ser1582 is just
upstream of the PfSUB2 cleavage site in a region of 35 amino
acid residues that have been proposed to mediate PfMSP1
dimerization on the merozoite surface (Babon et al., 2007).
Perhaps when S1582 is phosphorylated PfMSP1 cannot dimerize,
but when S1582 is dephosphorylated it can. Phosphorylation
of S116 and S1582 was reduced when merozoites were moved
from IC to EC buffer, and therefore we looked for protein
phosphatases that may be regulated by phosphorylation, for
example by upregulation of PfPKA-mediated phosphorylation.
We noticed potential PfPKA-mediated phosphorylation of Ser65
in PfPPM5 (GeneID: PF3D7_0810300) and of Ser164 and
Ser769 in PfPP7 (GeneID: PF3D7_1423300 – Supplementary
Table 3). Interestingly, S769 phosphorylation in PfPP7 increases
in extracellular merozoites (More et al., 2020) and it is possible
that phosphorylation increases the phosphatase activity of
PfPP7, leading to dephosphorylation of Ser116 and Ser1582
of MSP1, and this promotes merozoite invasion. Another
potential PfPKA-target residue is Ser106 in rhoptry associated
protein 1 (PfRAP1, GeneID: PF3D7_1410400); phosphorylation
of this residue also decreased in EC buffer, suggesting that
dephosphorylation of PfRAP1 Ser106 is also mediated by
either PfPPM5 or PfPP7. In contrast, while phosphorylation of
S106 decreased, the level of PfRAP1 phosphoSer183 increased,
clearly indicating that in extracellular merozoites the putative
PfPKA-mediated phosphorylation of a given protein (in this
case PfRAP1) can both increase and decrease, depending
on the particular target phosphosite. As described above,
another example of the complexity of phospho-regulation
is PfAMA1, where phosphorylation of S590 increases, while
the phosphorylation status of S610 remains unchanged, in
extracellular merozoites.
There are 16 putative PfPKA-target substrate proteins that
display increased phosphorylation at one or more sites, and
two substrate proteins whose phosphorylation decreases, when
merozoites are placed in EC extracellular buffer (listed in
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FIGURE 4 | PfPKA-mediated signaling protein interaction networks. Putative protein interaction networks associated with PfPKA signaling were generated by MCL
clustering analysis of the PfPKA substrate interactome comprised of 109 proteins (Supplementary Table 4) obtained from the STRING (https://string-db.org/)
database of protein–protein interactions. Sub-networks were annotated functionally by Gene Ontology terms on the basis of frequency and enrichment.
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Supplementary Table 2). For PfPKA, PfPPM5 and PfPP7 to
be responsible for altered phosphorylation of putative PfPKA-
target proteins they have to be in (transient) physical contact
with their substrates, and therefore caution is necessary, as we do
not know the subcellular compartments of PfPPM5 and PfPPM7.
The potential of all 18 proteins as therapeutic targets cannot
be discussed here, but clearly their possible role in merozoite
invasion, modulated by altered phosphorylation, is worthy of
detailed studies, as is the link between heightened PfPKA-
mediated phosphorylation and ubiquitylation in extracellular
merozoites. These substrates can now be investigated, for
example by genetic approaches, including identifying the
importance of individual phosphorylation sites, using CRISPR-
Cas9 technology.
TARGETING HOST PKA TO INHIBIT
DIFFERENT STAGES OF THE
Plasmodium LIFE CYCLE AND INHIBIT
OTHER APICOMPLEXAN INFECTIONS
The role of cAMP/PKA signaling in invasion of erythrocytes
by Plasmodium merozoites is well known, as described above.
Pharmacological inhibitors of mammalian cAMP regulatory and
responsive proteins can interfere with invasion (Syin et al., 2001;
Salazar et al., 2012). Furthermore, disruption of PfACβ (Patel
et al., 2019), PfPKAc (Patel et al., 2019; Wilde et al., 2019) and
PfPDEβ (Flueck et al., 2019) renders merozoites unable to invade
RBCs (Patel et al., 2019; Wilde et al., 2019). Infection of RBC
by P. falciparum leads to a rise in intra-erythrocyte cAMP levels
(Syin et al., 2001; Merckx et al., 2008; Dawn et al., 2014; Ramdani
et al., 2015), activating both host and parasite PKA and triggering
a phosphorylation cascade of both host (Bouyer et al., 2016) and
parasite (Lasonder et al., 2012, 2015) proteins, and contributing
to malaria pathogenesis.
However, cAMP signaling also plays an important role
at other stages in the parasite’s life cycle, for example in
hepatocyte invasion by Plasmodium sporozoites and gametocyte
transmission. cAMP is involved in sporozoite exocytosis
through the regulation of intracellular Ca2+ levels. P. berghei
parasites deficient in adenylyl cyclase α (PbACα, GeneID:
PBANKA_1037500) no longer exocytose during migration
through host cells, and lose hepatocyte infectivity in vivo (Ono
et al., 2008). cAMP-signaling is also involved in gametocyte-
infected erythrocyte (GIE) deformability. Reduced levels of
cAMP render stage V gametocytes less rigid and hence less likely
to be trapped and cleared by the reticuloendothelial system in
the spleen. Raising cAMP levels via pharmacological inhibition
of phosphodiesterases renders stage V gametocytes more rigid,
and therefore use of phosphodiesterase inhibitors has been
proposed as a strategy to block transmission of malaria parasites
(Ramdani et al., 2015).
Use of reverse phase protein microarray technology
demonstrated that Plasmodium yoelii infection impacts
hepatocyte regulatory pathways involved in cell survival,
proliferation, and autophagy. Decreased pro-apoptotic
phosphorylation of BAD (B-cell lymphoma [Bcl]-2 associated
FIGURE 5 | Summary of Plasmodium falciparum cyclic nucleotide signaling during erythrocyte invasion. Prior to merozoite egress PKG is activated by binding
cGMP, which is produced by the conversion of GTP to cGMP by GC. Activation of PKG induces an increase in intracellular Ca2+ and activation of
calcium-dependent kinases (CDPKs), which leads to secretion of apical proteins leading to egress of merozoites from mature schizonts. Egressed merozoites in
extracellular ionic conditions (EC) with low K+ levels activate ACβ that converts ATP to cAMP. PKAr, the regulatory subunit of PKA binds cAMP releasing the catalytic
subunit PKAc to phosphorylate specific target substrates that are listed in Supplementary Table 3. In extracellular merozoites PKA phosphorylates S590 in the
cytoplasmic tail of AMA1 and we hypothesize it locks AMA1 in an invasion competent conformation provoked by PKA-mediated S610 phosphorylation of AMA1
prior to merozoite release from red blood cells. Following merozoite egress, phosphorylation of both PKAr and CDPK1 increases to promote their binding to 14-3-3I,
so forming a multi-protein complex mediating secretion of microneme proteins such as AMA1 required for invasion. Phosphorylation of targets by various kinases is
indicated by solid arrows. Activation of kinases by second messengers is indicated with dotted arrows. Cyclic nucleotides are hydrolyzed by PDEα and PDEβ.
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death promotor) and increased levels of the apoptosis inhibitor
Bcl2 likewise contribute to an anti-apoptotic environment
promoting survival of the parasite in its host (Kaushansky
et al., 2013). It is known that Ser155 in BAD is preferentially
phosphorylated by PKA (Lizcano et al., 2000) and P. falciparum
infection leads to phosphorylation of a variety of cytosolic host
erythrocyte proteins, including BAD (Carvalho et al., 2016).
This suggests that cAMP-PKA signaling may also interfere with
an erythrocyte Bcl-dependent apoptosis mechanism to protect
against infected red blood cell death.
There is evidence that a prostaglandin-cAMP-PKA signaling
pathway may contribute to the pathogenesis of P. falciparum
asexual blood stages. Prostaglandins are known to modulate
cAMP concentrations and P. falciparum-infected RBCs produce
prostaglandins that may contribute to malaria-associated
pathology (Kilunga Kubata et al., 1998). For instance, induction
of heme oxygenase-1 expression by prostaglandin D(2) may be
involved in the pathogenesis of cerebral malaria (Kuesap and
Na-Bangchang, 2010). In addition, decreased cyclooxygenase-2
(COX2)-derived prostaglandin E2 (PGE2) levels enhanced
clinical severity in cerebral malaria (Perkins et al., 2001). In
addition, suppression of COX-2-derived PGE2 is associated with
reduced erythropoiesis and worsening anemia in children with
falciparum malaria (Anyona et al., 2012).
As in Plasmodium infection, cAMP-signaling contributes
to the pathogenesis of the related apicomplexan parasites
Theileria and Toxoplasma. In Theileria-infected and transformed
leukocytes, surges in cAMP concentration trigger a myriad
of cellular responses via activation of both PKA and EPAC
(exchange protein activated by cAMP) and their downstream
effectors. EPAC is a mediator of cAMP signaling distinct
from PKA and has two isoforms, EPAC1 and EPAC2,
which are also known as RAP (Ras-related protein) guanine
nucleotide exchange factors 3 and 4 (de Rooij et al., 1998;
Kawasaki et al., 1998). Higher levels of TGF-β2 stimulate
COX2 and Prostaglandin E Receptor 4 (EP4) expression
in virulent infected macrophages leading to a PGE2 auto-
stimulatory loop that modulates cAMP levels. Blocking PGE2-
signaling decreased cAMP levels, while activation of PGE2/EP4
signaling increased production of cAMP and stimulated adhesion
and Matrigel traversal (Haidar et al., 2015). A similar role
for PGE2 signaling in modulating cAMP levels has been
reported for HIV-infected macrophages (Hayes et al., 2002).
Also, cAMP regulates cytosolic Ca2+ levels via induction of
an EPAC/CaMKII/CREB pathway leading to an increase in
dissemination of Theileria-infected macrophages (Haidar et al.,
2015, 2017). Hexokinase-2 (HK2) binds to BAD only when
serine 155 in BAD is phosphorylated by PKA. Dissociation
of HK2/BAD complex by a penetrating peptide that acts as a
non-phosphorylatable BAD substrate provokes ubiquitination
and degradation of HK2 by the proteasome. Loss of HK
forces Theileria-transformed macrophages to switch from HK2-
dependent Warburg glycolysis to HK1-dependent oxidative
glycolysis, which dampens macrophage proliferation (Haidar
et al., 2017). Finally, cAMP fluxing impacts on the virulence of
Theileria-transformed leukocytes through modulation of H2O2
output (Haidar et al., 2019). cAMP induces CREB transactivation
to stimulate catalase transcription leading to increased catalase
activity and reduced H2O2 output (Haidar et al., 2019).
As in Theileria and Plasmodium infection, cAMP-signaling
plays a critical role in the pathogenesis of Toxoplasma. For
example, cAMP can have both stimulatory and antagonistic
effects on bradyzoite differentiation. A transient raise in cAMP
level promotes bradyzoite differentiation, whereas its prolonged
elevation inhibits this process (Kirkman et al., 2001). Moreover,
cAMP contributes to the neuropathology of Toxoplasma
infection by inducing CREB transactivation to drive miR-132
expression that downregulates D1-like dopamine receptors and
hence dopamine signaling (Xiao et al., 2014). Additionally,
pharmacological inhibition of PDE activity could be a promising
strategy for treatment of toxoplasmosis. Rolipram, a PDE4
inhibitor interferes with the transition ofToxoplasma to a chronic
phase of infection by increasing levels of intracellular cAMP, thus,
preventing biochemical and histological signs of Toxoplasma-
induced hepatitis in mice, as well as brain pathology of latent
toxoplasmosis (Afifi and Al-Rabia, 2015). Also, PDE4 inhibitors
can modulate the inflammatory response affecting conversion to
bradyzoites and pathological patterns of Toxoplasma infection
(Lyons et al., 2002; Sullivan and Jeffers, 2012).
TgPKA is involved in calcium-signal transduction in
Toxoplasma (Lourido et al., 2010). cAMP fluxes likely activate
TgPKAc1 (GeneID: TGGT1_242070) that stimulates microneme
secretion and tachyzoite egress from host cells (Lourido et al.,
2010). Furthermore, TgPKA is involved in stage interconversion
of tachyzoite to bradyzoite asexual stages of T. gondii mainly
via the catalytic subunit TgPKAc3 that is responsible for
maintenance of the tachyzoite stage during infection (Sugi et al.,
2016). Additionally, overexpression of TgPKAc1, or conditional
depletion of TgPKAr, leads to a defect in intracellular growth
(Jia et al., 2017).
Overall, there are multiple examples of how cAMP signaling
contributes to the pathogenesis of different apicomplexan
parasites. This argues that pharmacological manipulation of
cAMP levels and blockade of PKA-mediated signaling could be
an effective therapeutic strategy in the fight against disease caused
by apicomplexan parasites. In Figure 5 we present a scheme for
malaria parasites that highlights the different enzymes involved,
all of which are potential therapeutic targets.
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